课题基金 / 基金详情

Cocaine hydrolase gene therapy for cocaine abuse (DPI)

Cocaine hydrolase gene therapy for cocaine abuse (DPI)
可卡因水解酶基因疗法治疗可卡因滥用 (DPI)
批准号:
8100963
负责人:
WILLIAM Stephen BRIMIJOIN
金额:
$78.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2015-07-31

项目摘要

项目成果

WILLIAM Stephen BRIMIJOIN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该项目的目标是尽快开发一种有效和安全的新的可卡因滥用生物治疗方法,并使这种治疗方法达到适合临床试验的程度。将采用的方法是利用基因转移载体传递一种突变的人血浆丁基胆碱酯酶(BChE),这种酶能有效地将可卡因水解成基本上没有毒性和回报潜力的代谢物。来自动物研究的大量证据表明,这种方法能够预防和逆转可卡因毒性,同时也能减少自我给药的奖励刺激,并对抗药物引发的寻求药物行为的恢复。拟议的工作将扩展到包括非人灵长类动物,并将扩大与可卡因水解酶直接作为注射蛋白质和通过基因转移载体传递时的安全性有关的观察范围和细节。使用一系列药代动力学和行为模型,也将比以前更详细地检查治疗效果的性质和程度。在进一步完善体内载体驱动转导的酶编码序列后,还将关注在严格控制的条件下,以足够的数量生产最有效的载体以最终用于人类的问题。
英文摘要
DESCRIPTION (provided by applicant): The goals of this project are to move forward as rapidly as possible in developing an effective and safe new biological treatment for cocaine abuse and bring this treatment to the point at which clinical trials are appropriate. The approach that will be taken utilizes gene transfer vectors to deliver a mutated version of human plasma butyrylcholinesterase (BChE), which efficiently hydrolyzes cocaine into metabolites that are largely devoid of toxicity and reward potential. A body of evidence from animal studies indicates that such an approach is capable of preventing and reversing cocaine toxicity while also reducing reward stimulus from the self-administered drug and antagonizing drug-primed reinstatement of drug-seeking behavior. The proposed work will be extended to include nonhuman primates and will widen the range and detail of observations relating to the safety of the cocaine hydrolase enzyme when delivered directly as injected protein and when delivered by gene transfer vectors. The nature and magnitude of therapeutic effects will also be examined in more detail than previously, using a range of pharmacokinetic and behavioral models. After further refinement of enzyme coding sequences for vector driven transduction in vivo, attention will also be given to the issue of producing the optimally effective vector in adequate quantities and under rigorously controlled conditions for ultimate use in humans. PUBLIC HEALTH RELEVANCE: The practical outcome of the proposed work should be a convincing demonstration that gene therapy with a cocaine-destroying enzyme is a realistic prospect for treating cocaine users who are trying to become drug free and remain that way. If the project is successful, it will have shown that such a treatment is safe and effective in experimental animals and it will generate reagents that meet standards for use in humans. ADMINISTRATIVE NOTE ON SCORING: All NIDA Translational Avant Garde Award (DP1) applicants are e
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse
  • 批准号:
    10000864
  • 项目类别:
  • 资助金额:
    $85.38万
  • 财政年份:
    2016
  • 负责人:
    WILLIAM Stephen BRIMIJOIN
  • 依托单位:
Cocaine hydrolase gene therapy for cocaine abuse (DPI)
  • 批准号:
    8145645
  • 项目类别:
  • 资助金额:
    $76.48万
  • 财政年份:
    2010
  • 负责人:
    WILLIAM Stephen BRIMIJOIN
  • 依托单位:
Cocaine hydrolase gene therapy for cocaine abuse (DPI)
  • 批准号:
    8920215
  • 项目类别:
  • 资助金额:
    $11.87万
  • 财政年份:
    2010
  • 负责人:
    WILLIAM Stephen BRIMIJOIN
  • 依托单位:
Cocaine hydrolase gene therapy for cocaine abuse (DPI)
  • 批准号:
    8306233
  • 项目类别:
  • 资助金额:
    $76.48万
  • 财政年份:
    2010
  • 负责人:
    WILLIAM Stephen BRIMIJOIN
  • 依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    郑巧
  • 依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    陈立达
  • 依托单位: